Mar 19, 2021

Registration is open for Fall 2021 sessions of the monthly Responsible Conduct of Research (RCR) Seminar Series.

Mar 5, 2021

Changes include clarification of sites involved in the research, updating hyperlinks, and other updates to form instructions.

Mar 5, 2021

New HSR Portal Guidance is live! The portal webpage now lists guidance for the FAQs!

Mar 9, 2021

The CRSC will offer a protocol development workshop this spring. This workshop is intended for Junior Faculty, Fellows, and Residents of all disciplines pursuing a mentored research project.

Feb 24, 2021

The University of Colorado Anschutz Medical Campus (CU-Anschutz), University of Colorado Health system (UCHealth) and the Children’s Hospital Colorado (CHCO) use OnCore as a campus-wide platform to manage clinical research and facilitate fiscal and operational compliance. No research can be conducted in any facility without the proper approvals from the individual hospital and OnCore. All projects that are expedited or full board require OTA prior to enrolling participants.

Feb 16, 2021

As a result of recent changes, we are able to ramp up clinical research for review and scheduling of research visits for Groups 1-5. This change is effective February 19, but only for studies who have already been approved to resume research activity.

Feb 12, 2021

Occasionally, changes must be made to the HSR portal survey. If the “start over” button is selected when making changes, it will remove all responses from the form. Please use this option only when you need to delete every entry from your portal survey.

Feb 12, 2021

Looking for information on how to comply with NIH data sharing requirements, or a publisher's requirement to share data? You may find these resources helpful.

Feb 12, 2021

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19. The authorized use includes treatment for those who are 65 years of age or older or who have certain chronic medical conditions.

Feb 12, 2021

MyHealthConnection (MHC) is a secure patient message portal in Epic. With Research Administration, UCHealth Digital Patient Experience, and IRB approval, research recruitment messages may be sent in MHC. For participants already enrolled in a research study, MHC can be used to send IRB approved research related materials.